Breaking News

Over a quarter ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Rising High: Aurora Cannabis, Cronos Group appoint new CEOs » 10:14
09/10/20
09/10
10:14
09/10/20
10:14
ACB

Aurora Cannabis

$7.68 /

+0.035 (+0.46%)

, CRON

Cronos Group

$5.37 /

+0.09 (+1.70%)

, VFF

Village Farms

$5.78 /

+ (+0.00%)

, EMHTF

Emerald Health Therapeutics

$0.00 /

+ (+0.00%)

, CGC

Canopy Growth

$16.72 /

+0.365 (+2.23%)

, CVSI

CV Sciences

$0.00 /

+ (+0.00%)

, CRLBF

Cresco Labs

$0.00 /

+ (+0.00%)

, APHA

Aphria

$4.61 /

+0.095 (+2.10%)

, CTST

CannTrust

$0.64 /

+ (+0.00%)

, CANN

General Cannabis

$0.00 /

+ (+0.00%)

, IGC

India Globalization Capital

$1.24 /

-0.01 (-0.80%)

, TLRY

Tilray

$5.73 /

+0.1 (+1.78%)

, TCNNF

Trulieve Cannabis

$0.00 /

+ (+0.00%)

, ZYNE

Zynerba

$3.59 /

+0.02 (+0.56%)

In this week's "Rising…

ShowHide Related Items >><<
ZYNE Zynerba
$3.59 /

+0.02 (+0.56%)

VFF Village Farms
$5.78 /

+ (+0.00%)

TLRY Tilray
$5.73 /

+0.1 (+1.78%)

TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

IGC India Globalization Capital
$1.24 /

-0.01 (-0.80%)

EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CRON Cronos Group
$5.37 /

+0.09 (+1.70%)

CGC Canopy Growth
$16.72 /

+0.365 (+2.23%)

CANN General Cannabis
$0.00 /

+ (+0.00%)

APHA Aphria
$4.61 /

+0.095 (+2.10%)

ACB Aurora Cannabis
$7.68 /

+0.035 (+0.46%)

ACB Aurora Cannabis
$7.68 /

+0.035 (+0.46%)

09/09/20 Stifel
Aurora Cannabis price target lowered to C$10.50 from C$16 at Stifel
09/09/20 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$17.50 from C$29 at Cantor Fitzgerald
09/08/20 Ladenburg
Aurora Cannabis downgraded to Neutral at Ladenburg on slower progress
09/08/20 Ladenburg
Aurora Cannabis downgraded to Neutral from Buy at Ladenburg
CRON Cronos Group
$5.37 /

+0.09 (+1.70%)

09/09/20 Stifel
Cronos CEO transition 'natural part' of company's evolution, says Stifel
08/31/20 Roth Capital
Roth Capital believes MORE Act will not pass in 2020
06/24/20
Fly Intel: Top five analyst upgrades
06/24/20 Raymond James
Cronos Group upgraded to Outperform from Market Perform at Raymond James
VFF Village Farms
$5.78 /

+ (+0.00%)

09/08/20 Roth Capital
Roth says deal for PSF solidifies Village Farms as 'leading cannabis supplier'
09/08/20 Raymond James
Village Farms price target raised to $20 from $14 at Raymond James
08/25/20 Raymond James
Raymond James sees upside potential to $27 for Village Farms if PSF were bought
08/14/20 Stifel
Village Farms price target lowered to C$11 from C$15 at Stifel
EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

CGC Canopy Growth
$16.72 /

+0.365 (+2.23%)

08/11/20 Canaccord
Canopy Growth price target raised to C$22 from C$21 at Canaccord
07/02/20 HSBC
Constellation Brands price target raised to $170 from $147 at HSBC
06/24/20 Cantor Fitzgerald
Aurora Cannabis price target raised to C$29 from C$27 at Cantor Fitzgerald
CVSI CV Sciences
$0.00 /

+ (+0.00%)

06/12/20 Cowen
CV Sciences initiated with a Market Perform at Cowen
04/08/20 Raymond James
Ontario AG order positive for Canadian cannabis stocks, says Raymond James
04/07/20 Cantor Fitzgerald
CV Sciences a takeover target after patent approval, says Cantor Fitzgerald
CRLBF Cresco Labs
$0.00 /

+ (+0.00%)

08/21/20 Roth Capital
Cresco Labs price target raised to C$11 from C$8 at Roth Capital
08/21/20 Piper Sandler
Cresco Labs price target raised to $12 from $8 at Piper Sandler
07/22/20 Stifel
Cresco Labs re-initiated with a Buy at Stifel
07/07/20 Stifel
Stifel suspends coverage of cannabis names after analyst death
APHA Aphria
$4.61 /

+0.095 (+2.10%)

08/18/20 CIBC
Aphria upgraded to Outperformer with 'attractive' 25% upside at CIBC
08/17/20 CIBC
Aphria upgraded to Outperformer from Neutral at CIBC
07/30/20 CIBC
Aphria price target raised to C$7.50 from C$6 at CIBC
CTST CannTrust
$0.64 /

+ (+0.00%)

CANN General Cannabis
$0.00 /

+ (+0.00%)

11/05/19 BofA
BofA says Mexico cannabis legalization 'still in play' in 2020 after extension
10/10/19 Stifel
Hexo miss further damages cannabis industry credibility, says Stifel
IGC India Globalization Capital
$1.24 /

-0.01 (-0.80%)

TLRY Tilray
$5.73 /

+0.1 (+1.78%)

05/27/20 Roth Capital
Roth Capital sees Tilray operational moves as 'positive'
05/19/20 MKM Partners
Tilray price target raised to $8 from $5 at MKM Partners
05/12/20 Alliance Global Partners
Tilray price target lowered to $9 from $15 at Alliance Global Partners
TCNNF Trulieve Cannabis
$0.00 /

+ (+0.00%)

08/28/20 Canaccord
Trulieve Cannabis Florida market introduction bodes well, says Canaccord
08/12/20 Craig-Hallum
Trulieve Cannabis price target raised to $40 from $20 at Craig-Hallum
07/22/20 Stifel
Trulieve Cannabis re-initiated with a Buy at Stifel
ZYNE Zynerba
$3.59 /

+0.02 (+0.56%)

07/01/20 H.C. Wainwright
Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
07/01/20 Canaccord
Zynerba price target lowered to $12 from $18 at Canaccord
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
ZYNE Zynerba
$3.59 /

+0.02 (+0.56%)

TLRY Tilray
$5.73 /

+0.1 (+1.78%)

EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

CVSI CV Sciences
$0.00 /

+ (+0.00%)

CRON Cronos Group
$5.37 /

+0.09 (+1.70%)

CGC Canopy Growth
$16.72 /

+0.365 (+2.23%)

APHA Aphria
$4.61 /

+0.095 (+2.10%)

ACB Aurora Cannabis
$7.68 /

+0.035 (+0.46%)

CRON Cronos Group
$5.37 /

+0.09 (+1.70%)

ACB Aurora Cannabis
$7.68 /

+0.035 (+0.46%)

CRON Cronos Group
$5.37 /

+0.09 (+1.70%)

CRLBF Cresco Labs
$0.00 /

+ (+0.00%)

ACB Aurora Cannabis
$7.68 /

+0.035 (+0.46%)

ZYNE Zynerba
$3.59 /

+0.02 (+0.56%)

VFF Village Farms
$5.78 /

+ (+0.00%)

TLRY Tilray
$5.73 /

+0.1 (+1.78%)

IGC India Globalization Capital
$1.24 /

-0.01 (-0.80%)

CTST CannTrust
$0.64 /

+ (+0.00%)

CRON Cronos Group
$5.37 /

+0.09 (+1.70%)

CGC Canopy Growth
$16.72 /

+0.365 (+2.23%)

APHA Aphria
$4.61 /

+0.095 (+2.10%)

ACB Aurora Cannabis
$7.68 /

+0.035 (+0.46%)

Hot Stocks
Emerald Health's Pure Sunfarms JV ships branded products to Manitoba » 07:08
07/24/20
07/24
07:08
07/24/20
07:08
EMHTF

Emerald Health Therapeutics

$0.00 /

+ (+0.00%)

Emerald Health…

Emerald Health Therapeutics announced that its joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has begun shipping branded, packaged dried flower products to Manitoba's licensed private sector retailers, with these products available at the first 26 participating retailers in Manitoba beginning this week. Pure Sunfarms' products are now available in five of Canada's six most populous provinces, representing more than 70% of the Canadian population. Manitoba ranks as the sixth largest Canadian province by cannabis sales, comprising approximately 4.5% of the country's total sales and has a higher per capita spend on cannabis than the country average. In addition, the Pure Sunfarms brand achieved record sales in Ontario, British Columbia, and Alberta in aggregate for the four-week period ending July 19, 2020. Sales during the final week of that four-week period were also a record for a one-week period. Pure Sunfarms continues to rank as the top-selling dried flower brand at the Ontario Cannabis Store for the year to date. Pure Sunfarms is preparing to launch its first bottled oil and vape products in the coming weeks and continues to advance discussions with other provincial distributors for potential supply agreements to further expand its presence in the Canadian cannabis market.

ShowHide Related Items >><<
EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

Hot Stocks
Emerald Health completes accordion provision of Pure Sunfarms' credit facility » 07:22
07/01/20
07/01
07:22
07/01/20
07:22
EMHTF

Emerald Health Therapeutics

$0.00 /

+ (+0.00%)

Emerald Health…

Emerald Health Therapeutics announced that its joint venture for large-scale, low-cost cannabis production, Pure Sunfarms, has further expanded its credit facility with the lending syndicate led by Bank of Montreal and including Farm Credit Canada and the addition of CIBC to its full C$59M capacity with the completion of the Credit Facility's accordion feature. The Credit Facility now consists of a C$15M revolving operating loan and a C$25M term loan, in addition to its existing C$19M loan. The New Term Loan is specifically designated for the 1.1 million square foot Delta 2 greenhouse while the Existing Term Loan is specifically designated for the 1.1 million square foot Delta 3 greenhouse facility. Each of the components of the Credit Facility, including the Existing Term Loan, mature on February 7, 2022.

ShowHide Related Items >><<
EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

Hot Stocks
Pure Sunfarms' products ship to Saskatchewan, approved in Manitoba » 07:28
06/24/20
06/24
07:28
06/24/20
07:28
EMHTF

Emerald Health Therapeutics

$0.00 /

+ (+0.00%)

Emerald Health…

Emerald Health Therapeutics announced that its joint venture Pure Sunfarms has begun shipping branded, packaged dried flower products to Saskatchewan following approval from the Saskatchewan Liquor and Gaming Authority, which permits and monitors cannabis wholesalers and retailers in the province. Pure Sunfarms expects its products to be available to Saskatchewan consumers beginning next week. Pure Sunfarms has been accepted by the Manitoba Liquor and Lotteries Corporation as an official supplier of non-medical adult-use cannabis to the province's licensed private sector retailers and will begin shipping branded packaged products to Manitoba as soon as possible. Following the launch of Pure Sunfarms' products in Saskatchewan and Manitoba, they will be available in five of Canada's six most populous provinces, representing over 70% of the Canadian population. Pure Sunfarms continues to advance discussions to supply cannabis to other Canadian provincial distributors. Pure Sunfarms continues to prepare the roll-out of its first bottled cannabis oils and its first Cannabis 2.0 offerings this summer. Its Cannabis 2.0 roll-out will include a selection of pre-filled 510 vape cartridges and bottled cannabis oil, available in the extract forms of its dried cannabis strains.

ShowHide Related Items >><<
EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

Hot Stocks
Emerald Health working toward closing Avalite transaction in Q3 » 07:13
06/19/20
06/19
07:13
06/19/20
07:13
EMHTF

Emerald Health Therapeutics

$0.00 /

+ (+0.00%)

In March 2020, Emerald…

In March 2020, Emerald announced that it had signed a letter of intent under which Sigma Analytical Services, a full-service GMP-compliant testing laboratory for cannabis, hemp, and derived products, may acquire Emerald's Avalite analytical testing operation. The companies also intend to establish a preferred partner relationship. The due diligence process has been delayed due to COVID-19 but the parties continue to work toward closing the transaction in Q3 2020.

ShowHide Related Items >><<
EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

Earnings
Emerald Health Therapeutics reports Q1 revenue C$2.9M vs. C$2.1M » 07:11
06/19/20
06/19
07:11
06/19/20
07:11
EMHTF

Emerald Health Therapeutics

$0.00 /

+ (+0.00%)

Reports Q1 net loss…

Reports Q1 net loss C$4.9M. "In the first quarter and year to date, the benefits of Emerald's significant restructuring and cost-rationalization are strongly emerging. While these benefits were not fully realized in our Q1 financials, we can see our operational metrics and financial results clearly moving in the desired direction," said Riaz Bandali, President and CEO of Emerald. "In not even two full quarters, our two newly launched and scaled-up cultivation facilities in BC and Quebec have been achieving important milestones and are positioned to move us toward profitably. On top of that we own over 41% of one of the premiere large-scale cannabis cultivation operations in the country. We are very pleased with our asset portfolio, our operating team, and our prospects."

ShowHide Related Items >><<
EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

Earnings
Emerald Health reports Pure Sunfarms Q1 revenue C$18M vs. C$14.4M last year » 07:52
05/15/20
05/15
07:52
05/15/20
07:52
EMHTF

Emerald Health Therapeutics

$0.00 /

+ (+0.00%)

Sales for 1Q20 consisted…

Sales for 1Q20 consisted of approximately 10,365 kilograms of flower and trim at an average sales price of $1.74 per gram, compared to 1Q19 sales of approximately 4,140 kilograms of flower and trim at an average sales price of $3.47 per gram. Sales of branded retail products to provincial cannabis distribution boards in 1Q20 totaled 3,065 kilograms at an average price of $2.80, compared to nil in 1Q19 when all Pure Sunfarms sales were bulk cannabis sold in the wholesale channel. Sales to provincial boards in 1Q20 increased 118% from 4Q19, largely a result of the initial shipments for the launch and sale of product in Alberta. "We are pleased to see Pure Sunfarms continue to demonstrate solid traction in its transition into the retail market," said Riaz Bandali, President and Chief Executive Officer of Emerald. "The Pure Sunfarms team is also to be commended for their fifth consecutive quarter of profitability, which place it in a very unique and enviable position in the sector."

ShowHide Related Items >><<
EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

Hot Stocks
Emerald Health Therapeutics reduced workforce by approx. 60 employees » 07:47
05/14/20
05/14
07:47
05/14/20
07:47
EMHTF

Emerald Health Therapeutics

$0.00 /

+ (+0.00%)

A strategic restructuring…

A strategic restructuring that occurred throughout the second half of fiscal 2019 and into the first quarter of 2020, reduced Emerald's workforce by approximately 60 employees, significantly decreasing SG&A labour costs.

ShowHide Related Items >><<
EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

Earnings
Emerald Health Therapeutics reports FY19 revenue $20.3M vs. $1.9M last year » 07:46
05/14/20
05/14
07:46
05/14/20
07:46
EMHTF

Emerald Health Therapeutics

$0.00 /

+ (+0.00%)

"In the second half…

"In the second half of 2019 and through the beginning of 2020, our focus has been to cut costs, scale-up commercial production in our two wholly-owned cultivation facilities, and continue our progress toward positive cash flow and profitability," said Riaz Bandali, President and Chief Executive Officer of Emerald. "We have four distinct assets encompassing cultivation, post-harvest processing, and product development based on science and unique intellectual property. With these assets we continue our drive to create new consumer experiences with distinct recreational, medical and wellness-oriented cannabis and non-cannabis products, and we look forward to key steps through 2020."

ShowHide Related Items >><<
EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

EMHTF Emerald Health Therapeutics
$0.00 /

+ (+0.00%)

Hot Stocks
Emerald Health releases first harvest of cannabis from Richmond, BC facility » 07:41
04/06/20
04/06
07:41
04/06/20
07:41
EMHTF

Emerald Health Therapeutics

$0.00 /

+ (+0.00%)

Emerald Health…

Emerald Health Therapeutics has announced that the first shipment of its own unique version of the cannabis strain, Chemdog, from its 100%-owned Richmond facility is now available through the BC Liquor Distribution Board's online site and will become available in certain licensed cannabis retail stores in British Columbia. Emerald is expecting to receive orders from and ship this product to Alberta, Saskatchewan, and Manitoba in the next few weeks. Emerald's version of Chemdog, a sativa-dominant hybrid strain with 19-25% THC and 0-1% CBD, is the first of five unique strains that Emerald is growing and harvesting in its new Richmond, BC, operation. Linked to Nepalese and Thai sativa landraces and crossed by US breeders during the 1970s, Chemdog is a cultivar composed of OG Kush and Sour Diesel. The sticky buds and leaves appear silver from a coating of white trichomes that give off an earthy aroma of citrus and lavender with undertones of pepper and pine. The design of Emerald's Richmond growing operation allows access to sunshine in a natural sunbelt, while still being extremely close to key distribution and transportation hubs. The facility consists of two 78,000 square foot purpose-built greenhouses: the first one is fully licensed and now in full production; the second one is about 90% complete and should be completed by year-end. This facility employs the latest in state-of-the-art lighting and growing systems to achieve the greatest possible control and flexibility to optimize yield while also reducing environmental impact. Harvested cannabis is processed using artisanal drying, curing and trimming techniques to produce an authentic cannabis experience for its customers. The operation is certified by Pro-Cert Organic Systems, an accredited Canadian Food Inspection Agency, to the Canada Organic Regime. The facility is naturally growing cannabis in organic soil, which can be used over many years, is using approved organic pest management tools and fertilizers, and is on the path to produce fully organic cannabis. Emerald Richmond is rolling out product launches and is prepared to provide ongoing supply with a focus on Western Canada. Emerald will serve most of its eastern Canadian customers, including those in Quebec, from its second wholly-owned premium indoor grow operation, Verdelite, in St. Eustache, QC.

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.